Browse studies

Find your next paid study

27,370 recruiting studies available now

Deimplementation of Inappropriate Feeding Practices in Early Care and Education Settings

Arkansas and Louisiana have among the highest rates of adult obesity in the United States at 38.7% and 38.6%, respectively. Prevention and intervention efforts…

Obesity, Childhood

Estimated

~$10 – $750

Actual pay is set by the research site.

Arkansas Children's Hospital Research InstituteNCT07107321

Phase 3

A Randomized Phase III Study Comparing Temporally-Modulated Pulsed Radiation Therapy (TMPRT) Versus Standard Radiation Therapy With Temozolomide for Adults With Newly Diagnosed MGMT-Unmethylated Glioblastoma

This phase III trial compares temporally-modulated pulsed radiation therapy versus standard radiation therapy in treating patients with newly diagnosed, IDH wi…

Glioblastoma, IDH-WildtypeMGMT-Unmethylated Glioblastoma

Estimated

~$50 – $2,250

Actual pay is set by the research site.

NRG OncologyNCT07452458

Observational

Individual Placement and Support (IPS) for Serious Mental Illness in Jalisco, Mexico

There is substantial data to suggest that the Individual Placement and Support (IPS) model, a the investigatorsll-known, evidence-based practice, can help peop…

Severe Mental Disorder

Estimated

~$10 – $1,125

Actual pay is set by the research site.

Instituto Nacional de Psiquiatría Dr. Ramón de la FuenteNCT06019247

Phase 4

Corticosteroid for Diabetic Macular Edema (DME) Study

Our current goals include confirming inflammation mediators are biomarkers of DR and DME The Aim of this project is to measure aqueous PGE2 and inflammatory c…

Diabetic Macular Edema (DME)Diabetic Retinopathy

Estimated

~$25 – $1,000

Actual pay is set by the research site.

Vanderbilt University Medical CenterNCT07843849

Phase 1

A Phase 1 Adaptive Dose Escalation With Dose Expansion Study of Triapine in Combination With Temozolomide (TMZ) for Patients With Recurrent Glioblastoma

This phase I trial tests the safety, side effects, and best dose of triapine in combination with temozolomide in treating patients with glioblastoma that has c…

Recurrent Glioblastoma, IDH-WildtypeRecurrent WHO Grade 2 GliomaRecurrent WHO Grade 3 Glioma+1 more

Estimated

~$150 – $3,000

Actual pay is set by the research site.

Northwestern UniversityNCT06410248

Phase 1

A Phase IA/IB Trial of Leflunomide in Patients With PTEN-Altered Advanced Solid Malignancies and HER2 Negative Breast Cancer

Leflunomide in patients with PTEN-Altered advanced solid tumors or HER2 negative breast cancer. Phase 1A objectives are to determine the safety, tolerability, …

PTEN-Altered Advanced Solid Tumors and HER2 Negative Breast Cancer

Estimated

~$150 – $4,500

Actual pay is set by the research site.

Deborah DoroshowNCT04997993

Observational

Trauma Recovery Via EEG and Actigraphy Tracking (TREAT): Biomarkers of Written Exposure Therapy in PTSD

Posttraumatic stress disorder, or PTSD, can affect emotional health, sleep, daily functioning, and quality of life. Written Exposure Therapy is a brief trauma-…

Posttraumatic Stress Disorder (PTSD)

Estimated

~$10 – $750

Actual pay is set by the research site.

Mclean HospitalNCT07766798

Phase 2

The Role of Inflammation in Central Nervous System (CNS) Mechanisms of Anhedonia and Psychomotor Slowing in Depressed People With HIV

The purpose of this 10-week, double-blind, placebo-controlled study is to determine whether inflammation impacts reward and motor neural circuitry to contribut…

HIVDepressionAnhedonia

Estimated

~$75 – $2,000

Actual pay is set by the research site.

Emory UniversityNCT05849038

Mayo Clinic Precure - Prospective Study

The goal of this observational study is to 1) better understand and predict biological processes before disease begins or is identified, 2) study genomic and e…

Genetic PredispositionExposure, Environmental

Estimated

~$10 – $750

Actual pay is set by the research site.

Mayo ClinicNCT07332598

Phase 1

A Pilot Study Comparing Neoadjuvant and Adjuvant GVAX vs a Mutated KRAS Peptide Vaccine Given With Anti-PD-1 and Anti-CD137 for the Treatment of Surgically Resectable Pancreatic Adenocarcinoma

The purpose of this study is to determine the optimal dose of AGEN2373 that is safe when given in combination with balstilimab and Pancreatic GVAX Whole Cell V…

Pancreatic Cancer

Estimated

~$150 – $3,000

Actual pay is set by the research site.

Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsNCT06782932

Phase 1

A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Study to Evaluate Safety, Tolerability, and Pharmacokinetics of VK3019, an Amylin and Calcitonin Receptor Agonist, in Overweight and Obese Adults Without Comorbidities

This is a Phase 1, randomized, double-blind, placebo-controlled single ascending dose (SAD) study to evaluate the safety, tolerability, pharmacodynamics and ph…

Obese Adults

Estimated

~$150 – $4,200

Actual pay is set by the research site.

Viking Therapeutics, Inc.NCT07846033

Phase 2

Open-label Phase 2 Trial of AMB-05X for Patients With ctDNA(+) Colorectal Cancer After Curative-intent Treatment

To investigate the efficacy of AMB-05X in patients with CRC with MRD as determined by a ctDNA(+) blood test and no clinically detectable radiographic disease.

Colorectal Cancer

Estimated

~$75 – $2,000

Actual pay is set by the research site.

M.D. Anderson Cancer CenterNCT06617858